{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:31:43Z","timestamp":1786739503440,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>We present the case of a 46-year-old man who presented with bilateral panuveitis and occlusive retinal vasculitis 6 months after being acutely admitted with abnormal liver function and diagnosed with primary sclerosing cholangitis (PSC). Initial investigations by the medical and ophthalmic departments including all autoimmune investigations were within normal parameters. Of particular interest was the high likelihood of inadvertent androgenic-anabolic steroid self-suppression of disease. As a lifelong bodybuilder, the patient had been taking oral and intramuscular steroids for years. He became symptomatic upon cessation of these recreational medications. There remains a significant paucity of information describing the relationship between uveitis and PSC. Given the poorly understood aetiology of this rare cholestatic disease, we review the current literature and highlight the diagnostic and therapeutic challenges for such a patient. PSC may predispose patients to an occlusive panuveitis with androgenic-anabolic steroids suppressing ocular autoimmune disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/1319-4534.322598","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T16:04:52Z","timestamp":1627488292000},"page":"310-312","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Bilateral occlusive retinal vasculitis associated with primary sclerosing cholangitis"],"prefix":"10.4103","volume":"34","author":[{"given":"Abdus S.","family":"Ansari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catrin","family":"Bertalot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Mathews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Mathews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20240830","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1750-1172-7-57","article-title":"Uveitis- a rare disease often associated with systemic diseases and infections-a systematic review of 2619 patients","volume":"7","author":"Barisani-Asenbauer","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"R2-17-20240830","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ajo.2006.09.055","article-title":"Primary sclerosing cholangitis and uveitis: A case series","volume":"143","author":"Hoang","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"R3-17-20240830","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3748\/wjg.14.331","article-title":"Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease","volume":"14","author":"Saich","year":"2008","journal-title":"World J Gastroenterol"},{"key":"R4-17-20240830","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1055\/s-2006-933562","article-title":"Primary sclerosing cholangitis and cholangiocarcinoma","volume":"26","author":"Lazaridis","year":"2006","journal-title":"Semin Liver Dis"},{"key":"R5-17-20240830","first-page":"195","article-title":"The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease","volume":"67","author":"Kujundzi\u0107","year":"2013","journal-title":"Acta Med Croatica"},{"key":"R6-17-20240830","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1097\/MIB.0000000000000392","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"21","author":"Vavricka","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"R7-17-20240830","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2006-933561","article-title":"Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer","volume":"26","author":"Broom\u00e9","year":"2006","journal-title":"Semin Liver Dis"},{"key":"R8-17-20240830","first-page":"235","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"7","author":"Levine","year":"2011","journal-title":"Gastroenterol Hepatol (N Y"},{"key":"R9-17-20240830","doi-asserted-by":"crossref","first-page":"438402","DOI":"10.1155\/2015\/438402","article-title":"Ocular complications of inflammatory bowel disease","volume":"2015","author":"Mady","year":"2015","journal-title":"ScientificWorldJournal"},{"key":"R10-17-20240830","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000440707","article-title":"Association of extrahepatic manifestations with autoimmune hepatitis","volume":"33","author":"Wong","year":"2015","journal-title":"Dig Dis"},{"key":"R11-17-20240830","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3109\/09273948.2012.719994","article-title":"Ocular findings in patients with autoimmune liver disease","volume":"20","author":"Citirik","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"key":"R12-17-20240830","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3389\/fimmu.2018.00794","article-title":"Androgen-induced immunosuppression","volume":"9","author":"Gubbels Bupp","year":"2018","journal-title":"Front Immunol"},{"key":"R13-17-20240830","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/0192-0561(95)00078-X","article-title":"Modulation of immune responses by anabolic androgenic steroids","volume":"17","author":"Hughes","year":"1995","journal-title":"Int J Immunopharmacol"},{"key":"R14-17-20240830","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.4187\/respcare.02338","article-title":"Caution for anabolic androgenic steroid use: A case report of multiple organ dysfunction syndrome","volume":"58","author":"Unai","year":"2013","journal-title":"Respir Care"},{"key":"R15-17-20240830","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2478\/s11535-008-0058-x","article-title":"Anabolic androgenic steroids effects on the immune system: A review","volume":"4","author":"Marshall-Gradisnik","year":"2009","journal-title":"Open Life Sci"},{"key":"R16-17-20240830","doi-asserted-by":"crossref","first-page":"438","DOI":"10.2174\/138955711795445907","article-title":"Is there a potential immune dysfunction with anabolic androgenic steroid use. A review?","volume":"11","author":"Brenu","year":"2011","journal-title":"Mini Rev Med Chem"},{"key":"R17-17-20240830","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/2040622315605821","article-title":"A review of the medical treatment of primary sclerosing cholangitis in the 21st century","volume":"7","author":"Goode","year":"2016","journal-title":"Ther Adv Chronic Dis"}],"container-title":["Saudi Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/1319-4534.322598","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:29:29Z","timestamp":1786735769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1319-4534.322598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.4103\/1319-4534.322598","relation":{},"ISSN":["1319-4534"],"issn-type":[{"value":"1319-4534","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]}}}